
Dolby Laboratories (DLB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Dolby Laboratories (DLB) last issued guidance on July 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.25 - $4.4, compared to a consensus EPS estimate of $4.1. Dolby Laboratories also guided revenue in the range of $1.41B - $1.44B for the period.
Compared to prior guidance, Dolby Laboratories lowered its EPS outlook from a previous range of $4.3 - $4.45. On the revenue side, the company maintained its revenue forecast from a prior range of $1.4B - $1.45B.
Dolby Laboratories has issued 30 guidance updates between November 17, 2022 and July 30, 2026. During this period, the company raised its outlook 7 times and lowered it 15 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.62 | $1.28 | $0.84 | $0.60 |
| Actual | $0.69 | $1.37 | $1.06 | $0.99 |
| Surprise | +11.3% | +7.03% | +26.2% | +65.0% |
| Revenue | ||||
| Estimate | $312.3M | $384.6M | $338.0M | $305.6M |
| Actual | $305.0M | $395.6M | $346.7M | $307.0M |
| Surprise | -2.35% | +2.88% | +2.58% | +0.46% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.14 | $1.06 | $1.04 | $0.58 |
| Revenue | ||||
| Consensus | $371.9M | $358.3M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Jul 30, 2026 | $0.69 | $0.62 | 11.3 % |
| Q2 | Apr 30, 2026 | $1.37 | $1.28 | 7.03 % |
| Q1 | Jan 29, 2026 | $1.06 | $0.84 | 26.2 % |
| Q4 | Nov 18, 2025 | $0.99 | $0.60 | 65.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Jul 30, 2026 | $305.00M | $312.32M | -2.35 % |
| Q2 | Apr 30, 2026 | $395.63M | $384.57M | 2.88 % |
| Q1 | Jan 29, 2026 | $346.71M | $337.98M | 2.58 % |
| Q4 | Nov 18, 2025 | $307.02M | $305.61M | 0.46 % |